Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,077 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Active, Not Recruiting

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

NCT04207944

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Active, Not Recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

NCT07076121

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Mayo Clinic in Arizona - Phoenix Phoenix, Arizona, United States
  • Local Institution - 0365 Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Scripps Green Hospital La Jolla, California, United States
View all 269 locations
View Trial Details
Active, Not Recruiting

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

NCT06433219

Conditions
Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California San Francisco - UCSF Medical Center San Francisco, California, United States
  • Centricity Research Cancer Center - DBA CRRI John B. Amos Cancer Center Research Columbus, Georgia, United States
  • University of Chicago Comprehensive Cancer Center at Silver Cross - Carolyn J. Czerkies Pavilion Chicago, Illinois, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06625320

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center - Phoenix Phoenix, Arizona, United States
  • City of Hope-Duarte Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 60 locations
View Trial Details
Active, Not Recruiting

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT05445778

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Usa Mitchell Cancer Institute /ID# 269661 Mobile, Alabama, United States
  • Honorhealth Virginia G. Piper Cancer Care Network - Biltmore /ID# 269987 Phoenix, Arizona, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 269573 Irvine, California, United States
  • Moores Cancer Center at UC San Diego /ID# 269564 La Jolla, California, United States
View all 264 locations
View Trial Details
Active, Not Recruiting

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

NCT07120945

Conditions
Adenomyosis, Adenomyosis of Uterus, Adnexal Diseases, +38 more
Locations
  • Ascension St. Vincent's Riverside Jacksonville, Florida, United States
  • The University of South Florida Tampa, Florida, United States
  • Duke University Durham, North Carolina, United States
  • Allegheny Health Network - West Penn Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions